MONROVIA, Calif., Aug. 7, 2014 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that management will present at the following investor conferences:
The Wedbush 2014 Life Sciences Management Access Conference at the Le Parker Meridien Hotel in New York on Tuesday, August 12 at 10:20 a.m. PT/1:20 p.m. ET
The Canaccord Genuity 34th Annual Growth Conference at the InterContinental Hotel in Boston on Wednesday, August 13 at 10:00 a.m. PT/1:00 p.m. ET
Barry Caldwell, President and CEO, Hans Blickensdoerfer, President, Europe, Middle East, Latin America, and Steve Brown, CFO will offer a general overview of the Company's current business trends, recent financial results, and operational developments. A live webcast, including accompanying slides, will be available from the Company's website, under Investor Information. An archived replay of management's presentations will be available for 90 days following the event, also at www.staar.com.
About STAAR SurgicalSTAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." More than 450,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 335 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in Aliso Viejo, CA and Monrovia, CA. For more information, please visit the Company's website at www.staar.com.CONTACT:InvestorsMediaEVC Group
EVC GroupDoug Sherk
Nicole Kruse 415-652-9100
|SOURCE STAAR Surgical Company|
Copyright©2014 PR Newswire.
All rights reserved